
Results
8
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
8 companies
BlinkLab
Market Cap: AU$97.2m
Focuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing.
BB1
AU$0.73
7D
0.7%
1Y
162.5%
PolyNovo
Market Cap: AU$846.3m
Designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong.
PNV
AU$1.24
7D
-2.4%
1Y
-39.8%
Doctor Care Anywhere Group
Market Cap: AU$49.5m
Provides digital healthcare and development services in the United Kingdom and the Republic of Ireland.
DOC
AU$0.14
7D
0%
1Y
100.0%
Artrya
Market Cap: AU$614.6m
A medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia.
AYA
AU$3.60
7D
10.8%
1Y
650.0%
Austco Healthcare
Market Cap: AU$164.9m
Engages in the business of development, manufacture, service, supply, and distribution of healthcare communications equipment and software in Australia, New Zealand, Asia, Europe, and North America.
AHC
AU$0.43
7D
-2.8%
1Y
68.6%
Alcidion Group
Market Cap: AU$133.0m
Engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom.
ALC
AU$0.10
7D
15.4%
1Y
94.4%
CleanSpace Holdings
Market Cap: AU$57.1m
Designs, manufactures, and sells respirators and related products and services for people working in industrial and healthcare environments in the United Kingdom, rest of Europe, the Asia Pacific, North America, and internationally.
CSX
AU$0.69
7D
-1.4%
1Y
100.0%
Regis Healthcare
Market Cap: AU$2.3b
Engages in the provision of residential aged care services in Australia.
REG
AU$7.60
7D
2.8%
1Y
19.1%